Inflammatix, Inc. announced it raised $102 Million in an initial filing from an offering of $102 Million
Inflammatix, Inc. announced it raised $102 Million in an initial filing from an offering of $102 Million
03/24/21, 5:48 PM
Location
Money raised
$102 million
Industry
biotechnology
Company Info
Location
540 oakmead pkwy
sunnyvale, california, united states
Additional Info
Inflammatix is developing an innovative point-of-care instrument platform to be used with a test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response diagnostics. Our test rapidly informs the clinician about the likelihood of bacterial or viral infection and the need for ICU level care in the emergency department. Faster results may translate into more timely and appropriate therapy and level of care decisions.